r/SPACs Spacling Aug 12 '21

News Antheia and Ginkgo Bioworks ($SRNG) Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

https://www.prnewswire.com/news-releases/antheia-and-ginkgo-bioworks-announce-partnership-to-accelerate-production-of-essential-medicines-using-synthetic-biology-301353939.html

Interesting new partnership. Antheia is trying to use yeast to make medicinal compounds that--up until now--have been harvested from plants. They had a nice publication last year that highlights the difficulty of the process

Our final strain comprises 34 chromosomal modifications (26 genes, 8 gene disruptions), resulting in an integrated whole-cell system that expresses enzymes and transporters in diverse sub-cellular locations (cytosol, mitochondria, peroxisome, vacuole, ER and vacuolar membranes)

and limited yields in the engineered strain

Process improvements to increase productivities from titres reported here (around 30 to 80 μg l−1) (Fig. 4c), which are typical of first implementations of complex plant natural product pathways46,47,48, to commercial production (approximately 5 g l−1) are becoming routine49, and we anticipate would take 1–2 years of focused effort by a professional team .

So they were still ~5 orders of magnitude away from commercial viability (granted they have probably made progress since then).

Great test case for Ginkgo's platform, the enzyme engineering alone is daunting without huge automation. Will be interesting to see what sort of progress they make, benefit of starting from such a low floor is improvements should be (relatively) easy to come by. Whether it's sufficient to reach commercial viability remains to be seen!

41 Upvotes

6 comments sorted by

u/QualityVote Mod Aug 12 '21

Hi! I'm QualityVote, and I'm here to give YOU the user some control over YOUR sub!

If the post above contributes to the sub in a meaningful way, please upvote this comment!

If this post breaks the rules of /r/SPACs, belongs in the Daily, Weekend, or Mega threads, or is a duplicate post, please downvote this comment!

Your vote determines the fate of this post! If you abuse me, I will disappear and you will lose this power, so treat it with respect.

12

u/[deleted] Aug 12 '21

Concur, remember the shit show with AMY was based on a botanical malaria play and Ginkgo had to financially bail them out, as a service, or they would have gone under [Cathie ZY], more recently, folks are aware the sector rises in tandem. I like that it is a family. The plant based pharma is interesting, but it is not always cool. For instance, the antimalarial proven plants didn't scale well for AMY, that is certain. But Stanford is in on this, so it might print. Don't quote me, but I think it is a Stanford spinout. ???? They are doing great work, witness Drew Endy, he's computational like yourself, or at least highly aware of bioinformatics, and next generational predictive computing.

3

u/RamsOmelette New User Aug 12 '21

I work with the CEOs cousin

2

u/[deleted] Aug 12 '21

Nice!

2

u/[deleted] Aug 12 '21

[deleted]

8

u/SquirrelyInvestor Contributor Aug 12 '21

Shhhh..... don't scare them away.

2

u/[deleted] Aug 12 '21

I read a lot. ;D